SonoVanta cancer-margin imaging contrast agent
SonoVanta is a patent-pending contrast agent developed at George Mason University to enhance the precision of photoacoustic imaging. Licensed by NanOptical Biomedical, this technology facilitates improved visualization of diseased tissue, with applications ranging from advanced biomedical research to future clinical use in surgical oncology for optimizing breast tumor margin removal. It is set for commercial availability in the fall of 2026.
Overview
SonoVanta is a patent-pending contrast agent designed to enhance the precision of photoacoustic imaging, an advanced medical imaging technique that utilizes laser light and ultrasound. By improving the visualization of diseased tissue, this technology aims to overcome significant barriers to the broader adoption of photoacoustic imaging in biomedical research and clinical practice. It offers a scalable, robust platform for cell, tissue, and organ imaging, with significant potential to optimize the visualization of tumor margins during surgical oncology procedures.
Technical specifications
- Technology: Novel contrast agent for photoacoustic imaging based on self-assembled aggregates.
- Composition: Leverages an FDA-approved near-infrared dye, simplifying manufacturing and implementation.
- Core Advantages: Enables disease-specific targeting, reduces the reliance on complex chemical processes, and offers high reproducibility across production batches.
- Versatility: Can be adapted for various research needs, including the integration of fluorescent capabilities and refined targeting for specific diseases.
Technology readiness level
- The technology has been licensed to a biotech company (NanOptical Biomedical Inc.) to pursue commercial development and clinical applications. The product is scheduled for commercial availability as an advanced imaging tool in the fall of 2026, marking its transition from a laboratory-validated method to a commercialized product.
About George Mason University
George Mason University is a large comprehensive public research university serving the Washington, DC region through campuses in Fairfax, Arlington, and Prince William County. Its Arlington site anchors an innovation district that co-locates faculty, startups, and corporate partners, while Fairfax and Prince William host shared core labs and specialized facilities. Proximity to federal agencies and the Northern Virginia technology corridor enables collaborative R&D, sponsored projects, and robust internship and hiring pipelines. The university also maintains a close partnership with a major regional health system to support clinical research and translational studies. Research is supported by competitive federal funding from agencies such as NSF, NIH, and the Department of Defense, and a dedicated technology transfer office with incubator programs streamlines IP, licensing, and startup formation.
delivered to your inbox.